For the second time, Takeda Pharmaceuticals is trying to fend off claims that it didn't warn Actos patients about the diabetes drug's links to bladder cancer. Earlier this year, it lost the first case ...

Two plaintiffs' lawyers experienced in pharma liability litigation have been tapped to lead the group managing thousands of suits alleging that Takeda Pharmaceutical's diabetes drug Actos caused ...

Litigation over the drug Actos is gaining momentum as a mass tort. Lawyers around the country have begun filing lawsuits and investigating additional claims that the drug, prescribed to improve blood ...

The U.S. Chamber of Commerce and others in the defense bar that filed amicus briefs in the Actos case are pushing for the U.S. Court of Appeals for the Ninth Circuit to take up class certification ...

Takeda Pharmaceutical Co. didn’t hide the alleged bladder-cancer risks of its diabetes medicine Actos, a lawyer for the company told a jury in the sixth U.S. trial by patients who claim the drug ...

A Japanese pharmaceutical company prevailed Thursday in a Las Vegas case involving two women who claimed the diabetes drug Actos caused them to develop bladder cancer. Lawyers for the two women, Las ...

Takeda Pharmaceutical Co. and Eli Lilly and Co. on Monday were ordered to pay a combined $9 billion after a federal court jury found they hid the cancer risks of their Actos diabetes medicine in the ...